MedPath

QUININE SULFATE

These highlights do not include all the information needed to use QUININE Sulfate safely and effectively. See full prescribing information for QUININE Sulfate. QUININE Sulfate Capsules, USP for oral use. Initial U.S. Approval: 2005

Approved
Approval ID

b2f73c64-b92c-49bf-ad39-e32ac83e4d3d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 28, 2019

Manufacturers
FDA

Ingenus Pharmaceuticals, LLC

DUNS: 833250017

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

QUININE SULFATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50742-238
Application NumberANDA204372
Product Classification
M
Marketing Category
C73584
G
Generic Name
QUININE SULFATE
Product Specifications
Route of AdministrationORAL
Effective DateAugust 28, 2019
FDA Product Classification

INGREDIENTS (6)

QUININE SULFATEActive
Quantity: 324 mg in 1 1
Code: KF7Z0E0Q2B
Classification: ACTIB
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
GELATINInactive
Code: 2G86QN327L
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

QUININE SULFATE - FDA Drug Approval Details